FDC Ltd
FDC Ltd (FDC) last traded at ₹343, a market capitalisation of ₹5,586 crore, on a P/E of 18.1. Over the past 52 weeks the stock has ranged between ₹313 and ₹528. FDC Ltd last reported results for the quarter ended Jun 2026, with sales of ₹668 crore and net profit of ₹132 crore. Figures are as of 25 Aug 2026 and are not real time.
FDC Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
FDC Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹668 cr, up 3.1% from ₹648 cr a year earlier. Net profit was ₹132 cr, up 9.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 514 | 464 | 492 | 648 | 473 | 465 | 585 | 668 |
| Expenses | 444 | 417 | 438 | 508 | 439 | 412 | 478 | 525 |
| Operating profit | 70 | 47 | 54 | 140 | 34 | 52 | 106 | 143 |
| OPM % | 14% | 10% | 11% | 22% | 7% | 11% | 18% | 21% |
| Other income | 35 | 19 | 16 | 36 | 21 | 0 | 50 | 48 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 14 | 13 | 16 | 15 | 15 | 15 | 14 | 15 |
| Profit before tax | 90 | 51 | 53 | 160 | 38 | 36 | 140 | 175 |
| Tax % | 20% | 28% | 27% | 24% | 26% | 22% | 26% | 24% |
| Net profit | 72 | 37 | 39 | 121 | 28 | 28 | 103 | 132 |
| EPS (₹) | 4.42 | 2.28 | 2.38 | 7.45 | 1.74 | 1.74 | 6.35 | 8.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
FDC Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,331 | 1,525 | 1,784 | 1,943 | 2,108 | 2,171 | 2,190 |
| Operating profit | 334 | 254 | 251 | 339 | 325 | 346 | 335 |
| OPM % | 25% | 17% | 14% | 17% | 15% | 16% | 15% |
| Net profit | 301 | 216 | 194 | 305 | 267 | 281 | 293 |
| EPS (₹) | 17.85 | 12.82 | 11.70 | 18.75 | 16.39 | 17.29 | 17.97 |
TTM is the trailing twelve months to the most recent quarter.
FDC Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 10%
- 3 Years
- 7%
- TTM
- 3%
- 10 Years
- 6%
- 5 Years
- 1%
- 3 Years
- 16%
- TTM
- 14%
- 10 Years
- 6%
- 5 Years
- 0%
- 3 Years
- -3%
- 1 Year
- -27%
- 10 Years
- 13%
- 5 Years
- 12%
- 3 Years
- 13%
- Last Year
- 12%
FDC Ltd shareholding pattern
Promoters held 69.65% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.40% and DIIs 6.31%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.65% | 69.65% |
| FIIs | 2.62% | 2.67% | 2.56% | 2.41% | 2.43% | 2.32% | 2.40% | 1.40% |
| DIIs | 6.02% | 6.08% | 6.37% | 7.17% | 6.81% | 6.27% | 6.29% | 6.31% |
| Public | 21.71% | 21.60% | 21.42% | 20.76% | 21.10% | 21.76% | 21.65% | 22.63% |
| No. of shareholders | 55,400 | 55,228 | 53,880 | 54,445 | 54,157 | 53,788 | 52,730 | 55,045 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
FDC Ltd corporate filings
- This is to inform you that the company''s Subsidiary, FDC International Ltd., has received Marketing Authorisation from the MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.Company Updatemedium impact
Cruxal's analysis: FDC Ltd announced that its subsidiary, FDC International Ltd., has secured marketing…
Read the full analysis - Press Release Q1 FY 2026-27 Results.Company Updatehigh impact
Cruxal's analysis: FDC Limited reported Q1 FY27 consolidated revenue of 668 crore, a 3% YoY increase…
Read the full analysis - Outcome for the Board Meeting Held on 5th August, 2026.Board Meetinghigh impact
Cruxal's analysis: FDC Limited reported consolidated revenue from operations of 667.69 crore for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track FDC Ltd
Cruxal reads every FDC Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.